TECH Price / Book | BIO-TECHNE Corp

BIO-TECHNE Corp Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

BIO-TECHNE Corp price/book ratio for the quarter ending 2026-06-30 was 5.23, a 25.88% increase year-over-year.
BIO-TECHNE Corp price/book ratio for the quarter ending 2026-03-31 was 3.92, a 13.84% decline year-over-year.
BIO-TECHNE Corp price/book ratio for the quarter ending 2025-12-31 was 4.56, a 16.70% decline year-over-year.
BIO-TECHNE Corp price/book ratio for the quarter ending 2025-06-30 was 4.15, a 24.17% decline year-over-year.
BIO-TECHNE Corp price/book ratio for fiscal 2026 was 5.23.
BIO-TECHNE Corp price/book ratio for fiscal 2025 was 4.56, a 16.70% decline from fiscal 2024.
BIO-TECHNE Corp price/book ratio for fiscal 2024 was 5.47, a 11.38% decline from fiscal 2023.
BIO-TECHNE Corp price/book ratio for fiscal 2023 was 6.18, a 13.34% decline from fiscal 2022.

Available history: 2010-06-30 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	5.23	$11.03B	$2.11B
2026-03-31	3.92	$8.18B	$2.09B
2025-12-31	4.56	$9.17B	$2.01B
2025-06-30	4.15	$7.97B	$1.92B
2025-03-31	4.55	$9.19B	$2.02B
2024-12-31	5.47	$11.37B	$2.08B
2024-09-30	5.94	$12.7B	$2.14B
2024-06-30	5.48	$11.34B	$2.07B
2024-03-31	5.51	$11.09B	$2.01B
2023-12-31	6.18	$12.13B	$1.96B
2023-09-30	5.4	$10.78B	$2B
2023-06-30	6.54	$12.87B	$1.97B
2023-03-31	6.18	$11.67B	$1.89B
2022-12-31	7.13	$13.02B	$1.83B
2022-09-30	1.59	$2.79B	$1.75B
2022-06-30	7.98	$13.57B	$1.7B
2022-03-31	2.48	$4.25B	$1.71B
2021-12-31	2.99	$5.09B	$1.7B
2021-09-30	2.9	$4.76B	$1.64B
2021-06-30	2.81	$4.39B	$1.56B
2021-03-31	2.41	$3.71B	$1.54B
2020-12-31	2.02	$3.08B	$1.52B
2020-09-30	1.66	$2.39B	$1.44B
2020-06-30	1.84	$2.54B	$1.38B
2020-03-31	1.4	$1.81B	$1.29B
2019-12-31	1.59	$2.1B	$1.32B
2019-09-30	1.59	$1.86B	$1.17B
2019-06-30	1.7	$1.98B	$1.17B
2019-03-31	1.64	$1.88B	$1.15B
2018-12-31	1.25	$1.37B	$1.1B
2018-09-30	1.74	$1.93B	$1.11B
2018-06-30	1.29	$1.39B	$1.08B
2018-03-31	1.34	$1.42B	$1.06B
2017-12-31	1.21	$1.21B	$997.82M
2017-09-30	1.18	$1.13B	$960.08M
2017-06-30	1.16	$1.1B	$949.63M
2017-03-31	1.04	$948.73M	$907.93M
2016-12-31	1.08	$959.15M	$890.57M
2016-09-30	1.14	$1.02B	$895.37M
2016-06-30	1.19	$1.05B	$879.28M
2016-03-31	1.03	$878.95M	$852.96M
2015-12-31	0.98	$836.81M	$856.34M
2015-09-30	1.03	$859.47M	$837.95M
2015-06-30	1.08	$914.61M	$846.94M
2015-03-31	1.14	$931.52M	$820.07M
2014-12-31	1.04	$857.24M	$820.68M
2014-09-30	1.09	$866.03M	$793.41M
2014-06-30	1.08	$856.32M	$795.27M
2014-03-31	1.01	$788.09M	$777.04M
2013-12-31	1.17	$873.35M	$748.53M
2013-09-30	1.01	$737.61M	$726.76M
2013-06-30	0.86	$636.13M	$737.54M
2013-03-31	0.87	$624.94M	$719.51M
2012-12-31	0.91	$629.45M	$694.57M
2012-09-30	0.97	$662.37M	$680.61M
2012-06-30	1.01	$683.13M	$674.44M
2012-03-31	1	$645.93M	$644.5M
2011-12-31	1.05	$629.55M	$597.51M
2011-09-30	1.07	$629.17M	$589.35M
2011-06-30	1.32	$774.37M	$586.12M
2011-03-31	1.17	$664.34M	$566.28M
2010-12-31	1.12	$609.41M	$541.94M
2010-09-30	1.09	$571.82M	$523.57M
2010-06-30	1.06	$531.89M	$501.79M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	5.23	$11.03B	$2.11B
2025-12-31	4.56	$9.17B	$2.01B
2024-12-31	5.47	$11.37B	$2.08B
2023-12-31	6.18	$12.13B	$1.96B
2022-12-31	7.13	$13.02B	$1.83B
2021-12-31	2.99	$5.09B	$1.7B
2020-12-31	2.02	$3.08B	$1.52B
2019-12-31	1.59	$2.1B	$1.32B
2018-12-31	1.25	$1.37B	$1.1B
2017-12-31	1.21	$1.21B	$997.82M
2016-12-31	1.08	$959.15M	$890.57M
2015-12-31	0.98	$836.81M	$856.34M
2014-12-31	1.04	$857.24M	$820.68M
2013-12-31	1.17	$873.35M	$748.53M
2012-12-31	0.91	$629.45M	$694.57M
2011-12-31	1.05	$629.55M	$597.51M
2010-12-31	1.12	$609.41M	$541.94M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31
Krystal Biotech, Inc. (KRYS)	United States	$10.210B	45.56
HALOZYME THERAPEUTICS, INC. (HALO)	United States	$13.083B	21.59
Kymera Therapeutics, Inc. (KYMR)	United States	$9.631B	-31.69
ImmunityBio, Inc. (IBRX)	United States	$9.157B	-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)	United States	$14.131B	24.25
Vaxcyte, Inc. (PCVX)	United States	$8.466B	-7.91
EXELIXIS, INC. (EXEL)	United States	$14.358B	16.15
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78